Abdelaziz AO - Search Results

1

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.

Elsharkawy A, El-Raziky M, El-Akel W, El-Saeed K, Eletreby R, Hassany M, El-Sayed MH, Kabil K, Ismail SA, El-Serafy M, Abdelaziz AO, Shaker MK, Yosry A, Doss W, El-Shazly Y, Esmat G, Waked I. Elsharkawy A, et al. Among authors: abdelaziz ao. J Hepatol. 2018 Apr;68(4):691-698. doi: 10.1016/j.jhep.2017.11.034. Epub 2017 Dec 6. J Hepatol. 2018. PMID: 29223371

2

Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.

Zekri AR, Moharram RA, Mohamed WS, Bahnassy AA, Alam El-Din HM, Abo-Shadi MM, Zayed NA, El-Magzangy H, Abdel-Aziz AO, Esmat G. Zekri AR, et al. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):450-6. doi: 10.1097/MEG.0b013e3283329d00. Eur J Gastroenterol Hepatol. 2010. PMID: 19858727

3

IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.

El Awady MK, Bader El Din NG, Tabll A, El Hosary Y, Abdel Aziz AO, El Khayat H, Salama M, Abdelhafez TH. El Awady MK, et al. World J Gastroenterol. 2013 Jan 14;19(2):290-8. doi: 10.3748/wjg.v19.i2.290. World J Gastroenterol. 2013. PMID: 23345953 Free PMC article.

4

De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.

Abdelaziz AO, Nabil MM, Abdelmaksoud AH, Shousha HI, Cordie AA, Hassan EM, Omran DA, Leithy R, Elbaz TM. Abdelaziz AO, et al. Eur J Gastroenterol Hepatol. 2018 Jan;30(1):39-43. doi: 10.1097/MEG.0000000000001004. Eur J Gastroenterol Hepatol. 2018. PMID: 29064851

5

A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.

Abdelaziz AO, Shousha HI, Abdelmaksoud AH, Saad Y, Elbaz TM, Soliman ZA, Salah A, Lithy R, Ahmed M, Nabil MM. Abdelaziz AO, et al. Eur J Gastroenterol Hepatol. 2018 May;30(5):514-519. doi: 10.1097/MEG.0000000000001085. Eur J Gastroenterol Hepatol. 2018. PMID: 29465472

6

Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.

Abdelaziz AO, Shousha HI, Said EM, Soliman ZA, Shehata AA, Nabil MM, Abdelmaksoud AH, Elbaz TM, Abdelsalam FM. Abdelaziz AO, et al. Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1384-1388. doi: 10.1097/MEG.0000000000001196. Eur J Gastroenterol Hepatol. 2018. PMID: 30179227

7

Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients.

Abdelaziz AO, Nabil MM, Abdelmaksoud AH, Shousha HI, Hashem MB, Hassan EM, Salah A, Omran DA, Elbaz TM. Abdelaziz AO, et al. Eur J Gastroenterol Hepatol. 2019 Jan;31(1):75-79. doi: 10.1097/MEG.0000000000001264. Eur J Gastroenterol Hepatol. 2019. PMID: 30199473

8

Efﬁcacy and safety of sofosbuvir-based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience.

Yosry A, Gamal Eldeen H, Medhat E, Mehrez M, Zayed N, Elakel W, Abdelmoniem R, Kaddah M, Abdelaziz A, Esmat G, El-Serafy M, Doss W. Yosry A, et al. J Med Virol. 2019 Apr;91(4):668-676. doi: 10.1002/jmv.25362. Epub 2018 Dec 14. J Med Virol. 2019. PMID: 30549048

9

Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.

Abdelaziz AO, Abdelhalim H, Elsharkawy A, Shousha HI, Abdelmaksoud AH, Soliman ZA, Seif MI, Sayed DB, Farouk MH, Elbaz TM, Nabeel MM. Abdelaziz AO, et al. Eur J Gastroenterol Hepatol. 2019 Jun;31(6):685-691. doi: 10.1097/MEG.0000000000001343. Eur J Gastroenterol Hepatol. 2019. PMID: 30640743

10

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients.

Abdel Alem S, Elsharkawy A, El Akel W, Abdelaziz AO, Salama RM, El-Sayed MH, El Kassas M, Anees M, Shedeed M, Abdelsalam F, Ziada DH, El Shazly Y, El-Serafy M, Waked I, Esmat G, Doss W. Abdel Alem S, et al. Among authors: abdelaziz ao. Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):1009-1016. doi: 10.1080/17474124.2019.1653183. Epub 2019 Aug 16. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31418303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters